LongCovid
Why do some people infected with COVID-19 develop postacute sequelae of COVID-19 (PASC) while others do not?
This is the question that Herman et al. try to answer with this recently published study. The article shows that the presence of functional antibodies specific to OC43 (endemic human coronavirus) was enriched in PASC, suggesting immunological imprinting specific to OC43 may be a driver of PASC, particularly in individuals with prior rheumatic disease.
Study Highlights: – Reduced O2 pulse peak % predicted (impaired oxygen extraction) may be a mechanism of chronic fatigue and exercise intolerance in Long COVID. – The study identified…
Preliminary data recently published by Nature suggests that taking antiviral ensitrelvir, which is not approved in the United States, shortens symptoms in people with mild COVID and might…
In partnership with Patient-Led Research Collaborative, #MEAction has published its new Clinician’s Pacing Guide. #MEAction is an international organisation that works to develop and support a global network of individual…
Trying to find a solution to this challenge, researchers from KU Leuven, a research university in Belgium, have been working to develop evidence-based guidelines to help health professionals…